Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 21, 2008International Journal of Cancer

Rationale for folate receptor alpha targeted therapy in “high risk” endometrial carcinomas

View Full Paper
Ask AI
Bookmark
Share

Authors

MJMonica B. JonesMayo ClinicCNChristina NeuperMontanuniversität LeobenACAmy C. ClaytonMayo Clinic in Arizona

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jones et al. (2008) studied this question.

synapsesocial.com/papers/6ab3352fe0a077f45ceb1057https://doi.org/10.1002/ijc.23686
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer Statistics, 20072007 · 7,474 citations
  2. 2Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study2004 · 568 citations
  3. 3Vitamin B<sub>12</sub>and folate in relation to the development of Alzheimer’s disease2001 · 468 citations
  4. 4Role of folate receptor genes in reproduction and related cancers2006 · 100 citations
  5. 5Folate receptor overexpression is associated with poor outcome in breast cancer2007 · 245 citations